InvestorsHub Logo
Followers 125
Posts 17118
Boards Moderated 0
Alias Born 04/19/2006

Re: None

Tuesday, 02/24/2009 2:40:12 AM

Tuesday, February 24, 2009 2:40:12 AM

Post# of 28
Promising Multiple Sclerosis Treatment

BOS2331 writes: "BioMS Medical Corp. (MS.TO) is a Canadian company undergoing Phase 3 trials in Canada and Europe for its patented peptide treatment for multiple sclerosis, and its U.S. Phase 3 trials are just underway. To date, the trial has successfully passed six safety reviews and the drug has shown effectiveness in slowing the progression of secondary progressive multiple sclerosis (SPMS) with no relevant side effects. Interim data is expected in mid-2008.

"I believe it is the best and most effective MS treatment at this stage, and the pharmas are beginning to line up. The management team is a formidable group that is committed to bringing this drug to people."



"Dying Is Not Much Of A Living"
Josey Wales

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.